The purpose of this forum is to provide a forum for top researchers and young scientists from Japan and abroad in the fields of bacteriology, parasitology, virology, and immunology to meet and discuss the development of infection and immunology, and to integrate microbiology and immunology. The conference will have a new session on vaccinology, where research results from the AMED-SCARDA programs ”Japan Initiative for World-Leading Vaccine Research and Development Centers and Program on R&D of new generation vaccine including new modality application” will be presented.We look forward to your participation as well as that of the researchers participating in this project and their related parties, students, medical professionals, business people, and the general public who are interested in this research field.
Events 09/03/23-09/06/23 21st International Forum on Infection and Immunity in Awaji (AMED sponsored event)
21st International Forum on Infection and Immunity in Awaji
Date & Time
Karuizawa Prince Hotel (1016-75 Karuizawa, Karuizawa-cho, Kitasaku-gun, Nagano, 389-0193 Japan)
*The event will be held on-site. We do not rule out the possibility of a hybrid format depending on the situation, but please consider participating on-site as much as possible.
Pre-registration: General 30,000 yen, Students 10,000 yen
On-site registration: General 35,000 yen, Students 12,000 yen
How to Apply
Registration URL: http://awaji-forum.com/2023(Page will open in a new window.)
Pre-registration period: Wednesday, May 17, 2023 - Friday, August 25, 2023
Institute of Medical Science, The University of Tokyo
Center for Advanced Research and Development Strategies (SCARDA), Japan Agency for Medical Research and Development (AMED)
For inquiries regarding the International Forum on Awaji Infection and Immunity
Secretariat of the 21st International Forum on Awaji Infection and Immunity
For inquiries regarding the AMED SCARDA
E-mail: scarda-vf_office "AT"amed.go.jp
Inquiries should basically be sent by e-mail.
Please change the "AT" part of the above address to @ in the e-mail address.
Last updated 05/19/23